Oppenheimer Upgrades PROCEPT BioRobotics to Outperform, Announces $60 Price Target

Benzinga · 09/02/2025 12:22
Oppenheimer analyst Suraj Kalia upgrades PROCEPT BioRobotics (NASDAQ:PRCT) from Perform to Outperform and announces $60 price target.